GKOS
USDGlaukos Corporation Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$85.860
Máximo
$88.290
Mínimo
$85.235
Volumen
0.50M
Fundamentos de la Empresa
Capitalización de Mercado
4.9B
Industria
Dispositivos médicos
País
United States
Estadísticas de Negociación
Volumen Promedio
1.05M
Bolsa
NYQ
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its
JP Morgan Maintains Overweight on Glaukos, Raises Price Target to $120
JP Morgan analyst Allen Gong maintains Glaukos with a Overweight and raises the price target from $110 to $120.
Citigroup Maintains Buy on Glaukos, Raises Price Target to $113
Citigroup analyst Joanne Wuensch maintains Glaukos with a Buy and raises the price target from $110 to $113.
Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $122
Wells Fargo analyst Larry Biegelsen maintains Glaukos with a Overweight and raises the price target from $120 to $122.
Needham Maintains Buy on Glaukos, Raises Price Target to $117
Needham analyst David Saxon maintains Glaukos with a Buy and raises the price target from $115 to $117.
BTIG Maintains Buy on Glaukos, Raises Price Target to $116
BTIG analyst Ryan Zimmerman maintains Glaukos with a Buy and raises the price target from $104 to $116.
Glaukos Announces Third Quarter 2025 Financial Results
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.